MENINGOCOCCAL MENINGITIS MCM AT NEW DELHI - PowerPoint PPT Presentation

About This Presentation
Title:

MENINGOCOCCAL MENINGITIS MCM AT NEW DELHI

Description:

RESTRICTED TO NASOPHARYNX AS ASYMPTOMATIC CASES OR ONLY WITH LOCAL SYMPTOMS ... DIPLOCOCCUS. SIZE & SHAPE VARIATION IN OLDER CULTURES DUE TO AUTOLYSIS ... – PowerPoint PPT presentation

Number of Views:89
Avg rating:3.0/5.0
Slides: 33
Provided by: abc785
Learn more at: http://www.bibalex.org
Category:

less

Transcript and Presenter's Notes

Title: MENINGOCOCCAL MENINGITIS MCM AT NEW DELHI


1
MENINGOCOCCAL MENINGITIS (MCM) AT NEW DELHI
INDIA
Dr. A. K. AVASARALA MBBS, M.D. PROFESSOR
HEAD DEPT OF COMMUNITY MEDICINE
EPIDEMIOLOGY PRATHIMA INSTITUTE OF MEDICAL
SCIENCES, KARIMNAGAR, A.P. INDIA
91505417 avasarala_at_yahoo.com
2
  • PART-II
  • CLINICAL DISEASE, EPIDEMIOLOGY AND CONTROL

3
(No Transcript)
4
DEFINITION
  • IT IS A PYOGENIC INFECTION OF
  • MEMBRANES COVERING THE BRAIN
  • AND SPINAL CORD ( DURA, PIA AND
  • ARACNOID MEMBRANES) BY
  • MENIINGO-COCCI
  • ALSO CALLED CEREBROSPINAL FEVER

5
CLINICAL PRESENTATIONS
  • RESTRICTED TO NASOPHARYNX AS ASYMPTOMATIC CASES
    OR ONLY WITH LOCAL SYMPTOMS
  • INVASIVE WITH ACUTELY ILL SEPTICEMIC AND TOXIC
  • MENINGEAL

6
CLINICAL PICTURE IN THE NEWBORN
  • MINIMAL AND VARIABLE, HENCE DIAGNOSIS DIFFICULT
  • SLUGGISH, LETHARGIC WITH UNUSUAL GAZE
  • DOES NOT TAKE FEED WELL , MAY VOMIT
  • HIGH PITCHED CRY AND CONVULSIONS
  • HYPOTHERMIA SEEN USUALLY, FEVER MAY BE THERE
  • TENSE AND BULGING ANTERIOR FONTANELLAE VERY
    USUAL

7
CLINICAL PICTURE IN PRESCHOOL SCHOOL CHILD
  • WIDE SPECTRUM OF SIGNS SYMPTOMS IN THIS AGE
    GROUP AND MORE OBVIOUS
  • MODERATE TO HIGH FEVER
  • HEADACHE, VOMITING, PHOTOPHOBIA,
    CONVULSIONS,
  • NECK STIFFNESS,
  • NEUROLOGICAL IRRITATION
  • SKIN RASHES

8
CLINICAL PICTURE IN lt 2 YEAR OLD
  • CLASSICAL SIGNS MAY NOT BE PRESENT BUT HIGH
    DEGREE OF SUSPICION WHEN THE FOLLOWING PICTURE
    IS SEEN
  • FEVER COMMON
  • MACULOPAPULAR PETECHIAL RASH IN
  • HALF OF THE CASES
  • REFUSAL OF FEEDS
  • VOMITINGS,
  • ALTERED SENSORIUM
  • IRRITABILITY
  • BULGING FONTANELLAE
  • NEUROLOGICAL DEFICIT (EITHER MONOPLEGIA,
    HEMIPLEGIA AND SQUINT

9
CLINICAL PICTURE IN THE ADULT
  • CLEARCUT PICTURE
  • FEVER, INTENSE HEADACHE
  • VOMITING, PHOTOPHOBIA,
  • NECKPAIN AND STIFFNESS
  • SIGNS OF MENINGEAL IRRITATION
  • AND ALTERED SENSORIUM
  • SKIN RASHES
  • SIGNS AND SYMPTOMS OF SHOCK

10
DIFFERENTIAL DIAGNOSIS
  • IN NEONATE
  • SEPTICEMIA, GASTROENTERITIS, BIRTH HYPOXIA,
    BIRTH TRAUMA, RESPIRATORY INFECTIONS,
    HYPOGLYCEMIA, METABOLIC DISORDERS CAUSING
    CONVULSIONS AND KERNICTERUS
  • IN OLDER CHILDREN AND ADULTS
  • ENCEPHALITIS, BRAIN ABSCESS, CEREBRAL
    MALARIA, ASEPTIC MENINGITIS, CARDIOVASCULAR
    ACCIDENTS, CRYPTOCOCCAL MENINGIT IS AND
    TUBERCULAR MENINGITIS

11
DIAGNOSIS
  • MENINGOCOCCI ARE DEMONSTRATED BY LUMBAR
    PUNCTURE AND EXAMINATION OF CEREBRO SPINAL
    FLUID (CSF) CULTURE OF CSF
  • BLOOD CULTURE
  • CULTURE FROM NASOPHARYNX
  • EXAMINATION OF PETECHIAL SKIN LESIONS
  • IMMUNOLOGICAL METHODS FOR ANTIBODIES (IFP,
    ELISA, CIEP)

12
TREATMENT
  • ISOLATION OR SEPARATION
  • ALL PATIENTS NEED HOSPITALIZATION
  • SPECIFIC TREATMENT
  • - FLUIDS
  • - CEFTRIAXONE/CEFOTOXIME
  • - AMPICILLIN ( NOT TO BE GIVEN IF
  • HYPERSENSITIVE TO PENICILLIN)
  • - CHLORAMPHENICOL
  • SUPPORTIVE THERAPY FOR SHOCK AND
  • CONVULSIONS

13
EPIDEMIOLOGICAL INTERACTION
  • AGENT FACTORS

TIME DISRIBUTION

MCM
HOST FACTORS
ENVIRONMENT FACTORS
PERSON DISTRIBUTION
PLACE DISTRIBUTION
14
THE CAUSATIVE AGENT
  • NEISSERIA MENINGITIDIS
  • (MENINGO COCCUS)
  • BISCUIT SHAPED GRAM VE
  • DIPLOCOCCUS
  • SIZE SHAPE VARIATION IN OLDER CULTURES DUE TO
    AUTOLYSIS
  • TRANSPARENT ,NON PIGMENTED, NONHEMOLYTIC COLONIES
    1-5 MM SIZE

15
MENINGO COCCI
16
SERO GROUP TYPING
  • DEPEND UPON THE POLYSACCHARIDE CAPSULE
  • NINE SEROLOGICAL GROUPS IDENTIFIED
  • A, B, C, D, X , Y, Z , W-135, 29E
  • ALL THE SEROGROUPS ARE PATHOGENIC
  • BUT A, B, C, Y ARE MOST NEUROVIRULENT
  • A AND C ARE MOST EPIDEMOGENIC

17
MODE OF TRANSMISSION
  • HUMAN CASES AND THE CARRIERS ARE THE ONLY
    RESERVOIRS
  • TRANSMITTED BY DIRECT CONTACT
  • (DROPLETS,DISCARGE FROM THE NOSE THROAT OF
    THE PERSONS)
  • INCUBATION PERIOD 3-4 DAYS
  • PERIOD OF COMMUNICABILITY IS AS LONG AS THE
    MENINGOCOOCI ARE PRESENT IN DISCARGES FROM NOSE,
    THROAT AND NASOPHARYNX

18
PERSON FACTORS
  • POOR NUTRITIONAL STATUS IMMUNITY
  • DRY NASAL MUCOSA
  • PHYSICAL EXERTION
  • FATIGUE
  • CARRIER STATE

19
AGE PREDILICTION
  • PRIMARILY A CHILD DISEASE
  • BUT CAN AFFECT YOUNG
  • ADULTS ALSO

20
SEX PREDILICTION
  • MORE MALES ARE AFFECTED THAN FEMALES

21
PLACE DISTRIBUTION
  • MCM IS ENDEMIC IN LARGE TOWNS
  • MORE COMMONLY IN PEOPLE LIVING IN CROWDED
    CONDITIONS

22
TIME DISTRIBUTION
  • GREATEST INCIDENCE IN WINTER AND SPRING

23
CARRIER STATE
  • TRANSMISSION OCCURS MORE OFTEN FROM CARRIERS
    RATHER THAN CASES
  • BY AND LARGE HIGH CARRIER RATE IS USUALLY
    ASSOCIATED WITH OUTBREAKS

24
  • CONTROL MEASURES

25
VACCINATION
  • COMPOSITION 50 MICRO GRAMS OF A
    POLYSACHARIDE, 50 MICRO GRAMS OF C POLY
    SACHARIDE, 1 MG OF LACTOSE.
  • DOSE - 0.5 ML OF IRRESPECTIVE OF AGE GIVEN
    SUBCUTANEOUSLY.
  • EFFICACY SEROGROUP A CLINICAL EFFICACY
    85-95
  • SERO GROUP A INDUCES ANTIBODY RESPONSE IN
    CHILDREN AS YOUNG AS 3 MONTHS OLD.
  • BUT SEROGROUP C DOES NOT INDUCE ANTIBODIES
    BEFORE 2 YEARS OF AGE.
  • SEROGROUP Y AND W-135 ARE SAFE AND
  • IMMUNOGENIC IN ADULTS AND CHILDREN ABOVE
    AGE OF 2 YEARS.

26
VACCINATION LIMITATIONS
  • LIMITED SHELF LIFE AFTER REVACCINATION
  • NO VACCINE IS AVAILABLE AGAINST GROUP B
  • SHORT INCUBATION PERIOD vis-à-vis MORE TIME TAKEN
    FOR THE DEVELOPMENT OF IMMUNITY
  • 4.UNSATISFACTORY RESPONSE VACCINATION UNDER 2
    YEARS OF AGE WHICH IS THE HIGHEST SUSCEPTIBLE
    AGE-GROUP

27
PRESENT STRATEGY FOR VACCINATION
  • ONLY HIGH RISK PEOPLE (HEATH CARE WORKERS,
    TRAVELLERS, PEOPLE LIVING IN OVERCROWDED PLACES)
    AND CLOSE CONTACTS HAVE TO BE VACCINATED.

28
VACCINATION FOR CONTACTS
  • FORTUNATELY, WE HAVE QUADRIVALENT VACCINES AT
    PRESENT
  • PROTECTION OCCURS ONLY AFTER 14 DAYS OF
    VACCINATION
  • HENCE CHEMOPROPHYLAXIS IS PROVIDED WITH
    ANTIBIOTICS IN THE MEANTIME

29
VACCINATION FOLLOWED BY CHEMOPROPHYLAXIS FOR
CLOSE CONTACTS
  • HOUSEHOLD MEMBERS
  • DAY-CARE CENTRE CONTACTS
  • ANYONE DIRECTLY EXPOSED TO THE PATIENT'S ORAL
    SECRETIONS OR RESPIRATORY DROPLETS.

30
CHEMOPROPHYLAXISFOR CLOSE CONTACTS
  • WITHIN 24 HOURS FOR
  • HOUSEHOLD
  • CONTACTS
  • CLOSE CONTACTS
  • HIGH RISK PERSONS
  • CIPROFLOXACIN,
  • RIFAMPICIN,
  • MINOCYCLINE,
  • SPIRAMYCN,
  • CEFTRIAXIONE

WITH
31
RISK COMMUNICATION
  • THROUGH PUBLIC EDUCATION REGARDING
  • RISK FACTORS AND POSSIBLE CONTROL STRATEGIES
  • NOTIFICATION OF CASES AT THE EARLIEST
  • SURVEILLANCE

FOR ACTIVE AND SUSTAINED COMMUNITY
PARTICIPATION TO CONTROL THE EPIDEMIC
32
PUBLIC EDUCATION
  • AVOID OVERCROWDING.
  • DO NOT SHARE DRINKING BOTTLES, GLASSES,
    CIGARETTES, LIPSTICKS OR OTHER ITEMS THAT MAY BE
    COVERED IN SALIVA.
  • AVOID SMOKY AND DUSTY PLACES.
  • TEACH CHILDREN NOT TO SHARE CUPS, SOFT DRINK CANS
    OR SPORTS WATER BOTTLES.
Write a Comment
User Comments (0)
About PowerShow.com